Xencor, Inc. (XNCR)
23.39
-0.13
(-0.55%)
USD |
NASDAQ |
Oct 14, 16:00
23.40
+0.02
(+0.06%)
After-Hours: 20:00
Xencor Total Long Term Debt (Quarterly) : 166.19M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 166.19M |
| March 31, 2026 | 171.13M |
| December 31, 2025 | 184.48M |
| September 30, 2025 | 198.47M |
| June 30, 2025 | 209.57M |
| March 31, 2025 | 218.56M |
| December 31, 2024 | 228.94M |
| September 30, 2024 | 239.28M |
| June 30, 2024 | 246.91M |
| March 31, 2024 | 251.91M |
| December 31, 2023 | 248.51M |
| September 30, 2023 | 56.38M |
| June 30, 2023 | 54.62M |
| March 31, 2023 | 54.77M |
| December 31, 2022 | 54.93M |
| September 30, 2022 | 22.54M |
| June 30, 2022 | 33.94M |
| March 31, 2022 | 33.96M |
| December 31, 2021 | 33.97M |
| September 30, 2021 | 34.09M |
| June 30, 2021 | 2.702M |
| March 31, 2021 | 9.194M |
| December 31, 2020 | 9.739M |
| September 30, 2020 | 7.378M |
| June 30, 2020 | 7.626M |
| Date | Value |
|---|---|
| March 31, 2020 | 8.041M |
| December 31, 2019 | 8.565M |
| September 30, 2019 | 9.082M |
| June 30, 2019 | 9.65M |
| March 31, 2019 | 10.22M |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.002M |
| June 30, 2014 | 0.005M |
| March 31, 2014 | 0.007M |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 393.58M |
| UroGen Pharma Ltd. | 195.44M |
| MeiraGTx Holdings Plc | 110.06M |
| IDEAYA Biosciences, Inc. | 28.12M |
| Iovance Biotherapeutics, Inc. | 43.33M |